Quest Diagnostics Names Sukumar Nagendran, M.D., Vice President, Medical Affairs
News Apr 04, 2013
He reports to Jon R. Cohen, M.D., senior vice president and chief medical officer, and will be based at the company's headquarters in Madison, NJ.
"Dr. Nagendran has an impressive record of successful medical affairs in several clinical areas as well as in new product and business development and clinical trial operations," said Dr. Cohen. "These experiences, combined with his relationships with top medical and healthcare experts, will help us to engage medical opinion leaders, payers and clients in more productive dialogues about the composition and value of our services. These competencies are critical as our company strives to be more externally focused and responsive to market needs."
Most recently, Dr. Nagendran served as vice president, head of medical affairs at Reata Pharma. Prior to that, he was therapeutic-area head for new product development, medical affairs, clinical operations and biometrics, in which he oversaw several therapeutic areas, including oncology, cardiovascular disease and diabetes, for Daiichi Sankyo. He has held other senior positions related to clinical development and medical affairs for Pfizer and Novartis.
Dr. Nagendran also has significant clinical practice experience. Early in his career, Dr. Nagendran practiced in a large internal-medicine physician group and was a staff physician at three hospitals in Phoenix, Arizona. In addition, he is formerly a member of the PrimeCare managed care committee for Phoenix-based Banner Health Systems, one of the largest nonprofit healthcare systems in the United States.
Dr. Nagendran's research on cardiovascular disease, diabetes, oncology, pulmonary medicine and other areas of medicine has been published in a number of peer-reviewed publications, including Endocrine Practice, Current Medical Research & Opinion and Journal of Clinical Lipidology.
Dr. Nagendran earned a bachelor's degree in biochemistry from Rutgers University and earned his doctorate in medicine from UMDNJ-Robert Wood Johnson Medical School in New Jersey, where he was given the Robert Wood Johnson Alumni award for outstanding medical student. He completed his internal medicine training at The Mayo Clinic in Rochester, Minn., and was inducted into the prestigious Mayo Alumni Laureate Group.
Immune Cells That Keep Gut Fungi Under Control IdentifiedNews
Immune cells that process food and bacterial antigens in the intestines control the intestinal population of fungi, according to a new study from Weill Cornell Medicine scientists.READ MORE
Safety and Efficacy of MERS Treatment Confirmed in Phase I TrialNews
An experimental treatment developed from cattle plasma for Middle East respiratory syndrome (MERS) coronavirus infection shows broad potential, according to a small clinical trial. The treatment, SAB-301, was safe and well tolerated by healthy volunteers, with only minor reactions documented.READ MORE
Alzheimer’s Drug Discovery Foundation Announces $1.8M in New FundingNews
The Alzheimer’s Drug Discovery Foundation (ADDF) announces nearly $1.8 million in new funding, which reflects a commitment to advancing drugs in or near human clinical trials. All five funded programs are potential treatments for Alzheimer’s disease and other forms of dementia.READ MORE
Comments | 0 ADD COMMENT
Precision Medicine & Biomarkers Leaders Summit: USA
May 07 - May 08, 2018